Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Otonomy raises $10 million for disorders of the inner and middle ear

This article was originally published in Scrip

Executive Summary

Otonomy, which is developing therapies for disorders of the inner and middle ear, has raised a $10 million series A financing with Avalon Ventures. The proceeds will be used to fund the ongoing clinical trial of the US firm's lead product OTO-104 in Ménière's disease, toinitiate IND-enabling studies for its next product candidate OTO-203, and for early-stage development of a third programme, said the US firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC009132

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel